| Budget Amount *help |
¥18,200,000 (Direct Cost: ¥14,000,000、Indirect Cost: ¥4,200,000)
Fiscal Year 2012: ¥5,720,000 (Direct Cost: ¥4,400,000、Indirect Cost: ¥1,320,000)
Fiscal Year 2011: ¥5,720,000 (Direct Cost: ¥4,400,000、Indirect Cost: ¥1,320,000)
Fiscal Year 2010: ¥6,760,000 (Direct Cost: ¥5,200,000、Indirect Cost: ¥1,560,000)
|
|---|
| Research Abstract |
The status of counterfeit medicines in a developing country (Cambodia) was examined and compared with the global situation. It is concluded that target medicines of counterfeiters are similar in developing countries and the developed world, but medicines most widely used in the local area are more likely to be counterfeited, irrespective of their global importance. Substandard medicines are a huge problem in the pharmaceutical market in developing countries and improvements of quality control at manufacturing sites and distribution channels are urgently necessary.
|
